Oral Nicotine Pouch Marketing Features Influence on Perceptions
NCT ID: NCT06605924
Last Updated: 2026-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5133 participants
INTERVENTIONAL
2025-05-12
2025-11-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Nicotine Pouch Characteristics on Perceptions and Behavior
NCT06597435
Effects of an Oral Nicotine Product in Smokeless Tobacco Users
NCT05280769
Acute Effects of Oral Nicotine Pouches
NCT07128329
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims II: Laboratory Assessment of Sensory and Subjective Effects
NCT07107139
Acute Pharmacokinetic and Pharmacodynamic Effects of "Tobacco-Free" Oral Nicotine Pouches in Smokers
NCT05335915
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tobacco-free
Viewing a static advertisement
Tobacco-free
Ad contains baseline language + language that product is tobacco-free
Discrete
Viewing a static advertisement
Discrete
Ad contains baseline language + language that product is discrete
Convenient
Viewing a static advertisement
Convenient
Ad contains baseline language + language that product is convenient
Control
Viewing a static advertisement - baseline language only
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tobacco-free
Ad contains baseline language + language that product is tobacco-free
Discrete
Ad contains baseline language + language that product is discrete
Convenient
Ad contains baseline language + language that product is convenient
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For youth age \<21: Never used any nicotine pouch
* For adults: Smoked greater than or equal to 100 cigarettes in during lifetime
* For adults: Currently smoke some or all days
* For adults: No regular use of oral nicotine pouches
* For adults: No past 30-day pouch use
Exclusion Criteria
* For youth age \<21: Ever used nicotine pouches
* For youth age \<21: Greater than or equal to 100 lifetime uses of any other nicotine or tobacco product
* For adults: Smoked \<100 cigarettes in life
* For adults: Does not currently smoke some or all days
* For adults: Regular use of oral nicotine pouches
* For adults: Past 30-day pouch use
13 Years
120 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Johns Hopkins Bloomberg School of Public Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Meghan Moran, PhD
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
2213 McElderry St.
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00029102
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.